RecruitingPhase 4NCT04729686

The Pericapsular Nerve Block in Total Hip Arthroplasty

The Pericapsular Nerve Block in Total Hip Arthroplasty: A Randomized, Controlled Trial

Sponsor

LifeBridge Health

Enrollment

78 participants

Start Date

Dec 9, 2020

Study Type

INTERVENTIONAL

Conditions

hip osteoarthritis Hip Arthropathy

Summary

In order to continue progressing towards outpatient total hip arthroplasty (THA), methods to adequately manage postoperative pain is of paramount importance. The purpose of this study is to quantify the effectiveness of the pericapsular nerve block in total hip arthroplasty in comparison to the fascia iliaca nerve block.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Fascia Iliaca Nerve Block and a drug called Pericapsular Nerve Block for people with hip arthropathy and hip osteoarthritis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.